UNHHealthcare · Healthcare Plans

United HealthCare

DeepValues Research covers United HealthCare (UNH) with 14 research reports since Jan 27, 2026. The latest Deep Value Intelligence report (Jul 16, 2026) ends with a Neutral stance (2.51/5). Sector: Healthcare · Healthcare Plans. Neutral since Apr 14, 2026; 0 stance changes across 3 scored reports since Apr 14, 2026.

Latest stanceNeutral2.51
Reports14since Jan 27, 2026
Latest reportEN

Stance history

Neutral since Apr 14, 2026; 0 stance changes across 3 scored reports since Apr 14, 2026.

  1. Neutral2.68
  2. Neutral2.61
  3. Neutral2.51

Research timeline

  1. Deep Value Intelligence

    United HealthCare (UNH) Deep Value Intelligence Report

    Neutral (2.51/5) on United HealthCare (UNH), Jul 16, 2026. Price $423. UnitedHealth remains a very large, durable healthcare franchise with scale…

    Neutral2.51EN38 min
  2. Deep Value Intelligence

    United HealthCare (UNH) Deep Value Intelligence Report

    Neutral (2.61/5) on United HealthCare (UNH), May 8, 2026. Price $380. UnitedHealth Group (UNH) is a fundamentally exceptional, wide-moat business…

    Neutral2.61EN52 min
  3. Deep Value Intelligence

    United HealthCare (UNH) Deep Value Intelligence Report

    Neutral (2.68/5) on United HealthCare (UNH), Apr 14, 2026. Price $314. - Bullish / Risk-Seeking View - The bullish argument centers on the transformation…

    Neutral2.68EN中文33 min
  4. Deep Value Intelligence

    United HealthCare (UNH) Deep Value Intelligence Report

    Deep Value Intelligence report on United HealthCare (UNH), Mar 14, 2026. Price $282. While UNH possesses a massive, undeniable moat, the unpredictability…

    EN中文38 min
  5. Research note

    UnitedHealth Group (UNH) Financial Research Report

    UnitedHealth Group's latest earnings (Q3 2025) showed revenue growth but significantly lower profit margins due to higher medical costs. Revenue rose 12%…

    EN54 min
  6. Research note

    UnitedHealth Group (UNH) Financial Research Report

    UnitedHealth Group is the largest private‑sector health insurer in the United States with a diversified platform spanning insurance, care delivery…

    EN5 min
  7. Research note

    UnitedHealth Group (UNH) Deep Research Report

    UnitedHealth Group reported mixed Q2 2025 results amid cost pressures and updated its full-year outlook. Revenue for the quarter was $111.62 billion, up…

    EN30 min
  8. Research note

    United Health Care (UNH) - Updated May-13

    I will update the UnitedHealth Group (UNH) financial report with the latest data and changes. I will retrieve recent financial metrics, update forecasts…

    EN2 min
  9. Research note

    UnitedHealth Group Under the Microscope: An Analysis of the Steve Eisman Thesis

    UnitedHealth Group (UNH), the undisputed behemoth of the American healthcare landscape, finds itself at a critical inflection point. Long celebrated for…

    EN23 min
  10. Q4 2025

    The Reshape of an Empire: A Strategic and Financial Post-Mortem of UnitedHealth Group's 2025 "Great Reset"

    The Reshape of an Empire: A Strategic and Financial Post-Mortem of UnitedHealth Group's 2025 "Great Reset" · UNH · Feb 19, 2026: The fiscal conclusion of…

    EN20 min
  11. Deep Value Intelligence

    United HealthCare (UNH) Deep Value Intelligence Report

    Deep Value Intelligence report on United HealthCare (UNH), Feb 15, 2026. The debate reveals a severe dislocation between the stock's performance and its…

    EN33 min
  12. Q4 2025

    UNH Q4 2025 Deep Value Analysis

    UnitedHealth Group (UNH) reported 4Q 2025 earnings highlighting robust revenue growth but sharply lower net profit due to one-time charges…

    EN32 min

Compare with other Healthcare companies

All Healthcare stocks
CompanyIndustryLatest stancePrice · valueDateReports
UNHUnited HealthCare Healthcare Plans Neutral2.51 $423 14
OSCROscar Health Healthcare Plans Bearish2.77 $22 1
MOHMolina Healthcare Healthcare Plans Neutral2.57 $186 1
JNJJohnson & Johnson Drug Manufacturers - General Neutral3.08 $264 · $184 3
GRDN Medical Care Facilities Bearish3.16 $40 · $14 1
ALLOAllogene Therapeutics Biotechnology Bearish3.10 $1 1
MRNA Biotechnology Neutral3.01 $199 · $448 1
CRSPCRISPR Therapeutics Biotechnology Neutral2.30 $56 1
INSMInsmed Biotechnology Bearish2.52 $118 1

Charts from the latest report

Open report